跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
劉 家宏
副教授
,
泌尿學科
成員
,
臺北醫學大學泌尿腎臟研究中心
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0003-2327-1295
電子郵件
mexxliu
tmu.edu
tw
h-index
1418
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2025
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(46)
類似的個人檔案
(6)
指紋
查看啟用 Chia-Hung Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
2,5-Dimethoxy-4-iodoamphetamine
9%
Alginic Acid
48%
Amino Acid
9%
Apoptosis Inhibitor
9%
Biocompatibility
19%
Bladder Cancer
33%
Calcium Phosphate
9%
Chemotherapy
14%
Chitosan
24%
Chlamydomonas reinhardtii
15%
Chronic Kidney Failure
15%
Cisplatin
9%
Combination Therapy
11%
Drug Delivery System
15%
Fibrinolytic Agent
29%
Fucoidan
13%
Gold Nanorod
28%
Hydroxyapatite
28%
Hyperthermia
28%
Inflammation
24%
Injury
14%
Intracellular Drug Delivery
21%
Iron Oxide
14%
Kidney Fibrosis
10%
Liver Cancer
10%
Magnesium Ion
9%
Mesoporous Silica Nanoparticle
9%
Metal Organic Framework
21%
Microsphere
18%
Monocyte Chemotactic Protein 1
9%
Mouse
9%
Mouse Model
24%
Mouth Squamous Cell Carcinoma
18%
Nanocarrier
11%
Nanomaterial
10%
Nanoparticle
77%
Narcotic Agent
9%
Neoplasm
33%
P-Selectin
11%
Pembrolizumab
9%
Photothermal Therapy
29%
Polyacrylic Acid
9%
Polypyrrole
22%
Prostate Cancer
18%
Prostate Specific Antigen
9%
Thrombosis
20%
Thrombus
34%
Tumor Microenvironment
10%
Ureter Obstruction
9%
Withaferin A
9%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
9%
Apoptosis Inhibitor
9%
Bioglass
9%
Biomimetics
9%
Blood Clot Lysis
21%
Bone Regeneration
9%
Diabetes
9%
Diabetes Mellitus
9%
Dipyridamole
9%
Extracorporeal Shock Wave Lithotripsy
9%
Functional Disease
9%
Genitourinary System
9%
Gold Nanorod
9%
Hemostat
9%
Hyperthermia
9%
Inflammatory Disorder
9%
Injury
9%
Ischemia
9%
Ischemic Injury
11%
Macrophage
9%
Magnesium
9%
Magnesium Ion
9%
Metal Organic Framework
9%
Microhematuria
9%
Mouth Squamous Cell Carcinoma
9%
Nanocarrier
9%
Nanoparticle
11%
Orthopedics
9%
Osteoplasty
9%
PADGEM Protein
10%
Pembrolizumab
9%
Percutaneous Nephrolithotomy
9%
Photothermal Therapy
10%
Platelet
18%
Platelet Lysate
9%
Polyacrylic Acid
9%
Polypyrrole
9%
Prostate Cancer
9%
Prostate Specific Antigen
9%
Recurrent Disease
6%
Side Effect
9%
Smooth Muscle Relaxation
9%
Targeted Therapy
9%
Thrombolytic Drug
20%
Thrombosis
19%
Thrombus
30%
Ultrasmall Superparamagnetic Iron Oxide
9%
Urethra Stenosis
9%
Urethrotomy
9%
Urolithiasis
9%
Material Science
Aluminum Oxide
9%
Amino Acids
9%
Biocompatibility
27%
Bioglass
9%
Curcumin
14%
Gold Nanoparticle
5%
Hydrogel
14%
Iron Oxide
48%
Macrophage
17%
Magnesium
9%
Magnesium Ion
9%
Metal-Organic Framework
37%
Molybdate
9%
Molybdenum
10%
Nanoclusters
9%
Nanocrystalline Material
13%
Nanoparticle
100%
Nanorod
9%
Nanozymes
9%
Platelet
37%
Platinum
9%
Polymer Nanoparticles
9%
Polypyrrole
16%
Polysiloxane
9%
Silicon Dioxide
9%
Surface Texture
9%
Thin Films
18%
Titanium Dioxide
9%
Tumor
29%
